Search Results

Filter
  • 1-10 of  12,147 results for ""Apolipoprotein B-100""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL.

  • Authors : Kobayashi M; Departments of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.; Watanabe K

Subjects: Acrolein/Acrolein/Acrolein/*chemistry ; Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*chemistry ; Cholesterol, LDL/Cholesterol, LDL/Cholesterol, LDL/*chemistry

  • Source: Biochimica et biophysica acta. Molecular and cell biology of lipids [Biochim Biophys Acta Mol Cell Biol Lipids] 2021 Jan; Vol. 1866 (1), pp. 158809. Date of Electronic Publication: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731727 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Dynamics of Apolipoprotein B-100 in Interaction with Detergent Probed by Incoherent Neutron Scattering.

  • Authors : Cisse A; Université Grenoble Alpes, CNRS, LiPhy, 38000 Grenoble, France.; Institut Laue Langevin, 38042 Grenoble, France.

Subjects: Molecular Dynamics Simulation*; Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*chemistry ; Detergents/Detergents/Detergents/*chemistry

  • Source: The journal of physical chemistry letters [J Phys Chem Lett] 2021 Dec 30; Vol. 12 (51), pp. 12402-12410. Date of Electronic Publication: 2021 Dec 23.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101526034 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Common Bean Baked Snack Consumption Reduces Apolipoprotein B-100 Levels: A Randomized Crossover Trial.

  • Authors : Escobedo A; Tecnología Alimentaria, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco (CIATEJ), A.C., Camino Arenero #1227 Col. El Bajío, Zapopan 45019, Mexico.; Rivera-León EA

Subjects: Phaseolus*; Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*blood ; Eating/Eating/Eating/*physiology

  • Source: Nutrients [Nutrients] 2021 Oct 29; Vol. 13 (11). Date of Electronic Publication: 2021 Oct 29.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analytical Performance Specifications for Lipoprotein(a), Apolipoprotein B-100, and Apolipoprotein A-I Using the Biological Variation Model in the EuBIVAS Population.

  • Authors : Clouet-Foraison N; Northwest Lipid Metabolism and Diabetes Research Laboratories, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA.; Marcovina SM

Subjects: Biological Variation, Individual*; Apolipoprotein A-I/Apolipoprotein A-I/Apolipoprotein A-I/*blood ; Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*blood

  • Source: Clinical chemistry [Clin Chem] 2020 May 01; Vol. 66 (5), pp. 727-736.Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Differentially Regulated Apolipoproteins and Lipid Profiles as Novel Biomarkers for Polypoidal Choroidal Vasculopathy and Neovascular Age-Related Macular Degeneration.

  • Authors : Zhang X; Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.; Beijing Retinal and Choroidal Vascular Disorders Study Group, Beijing, China.

Subjects: Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/biosynthesis ; Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/metabolism ; Apolipoproteins B*/Apolipoproteins B*/Apolipoproteins B*/biosynthesis

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jul 19; Vol. 13, pp. 946327. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

×
Academic Journal

Five Variable Number of Tandem Repeats Loci (D17S5, APOB, TPO Intron 10, IL-1α Intron 6, and CIAS1) in Thais and Application in the Prenatal Diagnostic Laboratory.

  • Authors : Singsanan S; Department of Medical Technology, Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.; Yamsri S

Subjects: Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/genetics ; Autoantigens*/Autoantigens*/Autoantigens*/genetics ; Interleukin-1alpha*/Interleukin-1alpha*/Interleukin-1alpha*/genetics

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2022 Jun; Vol. 26 (6), pp. 324-330.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.

  • Authors : Youssef A; Robarts Research Institute (A.Y., M.B.B., M.L.K.), Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Canada.; Clark JR

Subjects: Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*metabolism ; Apolipoproteins A/Apolipoproteins A/Apolipoproteins A/*metabolism ; Hepatocytes/Hepatocytes/Hepatocytes/*metabolism

  • Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2022 Mar; Vol. 42 (3), pp. 289-304. Date of Electronic Publication: 2022 Jan 20.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.

  • Authors : Yoshikawa M; Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan. .; Asaba K

Subjects: Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/blood ; Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/genetics ; COVID-19*/COVID-19*/COVID-19*/blood

  • Source: BMC medical genomics [BMC Med Genomics] 2021 Nov 13; Vol. 14 (1), pp. 269. Date of Electronic Publication: 2021 Nov 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794

Record details

×
Academic Journal

Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.

  • Authors : Wu H; Department of Epidemiology, Biostatistics and Occupational Health (H.W., J.B.R.), McGill University, Montréal, Québec, Canada.; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital (H.W., V.F., J.B.R.), McGill University, Montréal, Québec, Canada.

Subjects: Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/blood ; Apolipoprotein B-100*/Apolipoprotein B-100*/Apolipoprotein B-100*/genetics ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/blood

  • Source: Circulation. Genomic and precision medicine [Circ Genom Precis Med] 2021 Oct; Vol. 14 (5), pp. e003312. Date of Electronic Publication: 2021 Aug 31.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101714113 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration.

  • Authors : Ma L; School of Biomedical Sciences, University of Western Australia, Perth, Australia; School of Medicine, University of Western Australia, Perth, Australia.

Subjects: Apolipoprotein B-100/Apolipoprotein B-100/Apolipoprotein B-100/*metabolism ; Apolipoproteins A/Apolipoproteins A/Apolipoproteins A/*metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use

  • Source: Metabolism: clinical and experimental [Metabolism] 2019 Jul; Vol. 96, pp. 8-11. Date of Electronic Publication: 2019 Apr 14.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0375267 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  12,147 results for ""Apolipoprotein B-100""